Literature DB >> 18480457

Efficient trans-encapsidation of hepatitis C virus RNAs into infectious virus-like particles.

Eike Steinmann1, Christiane Brohm, Stephanie Kallis, Ralf Bartenschlager, Thomas Pietschmann.   

Abstract

Recently, complete replication of hepatitis C virus (HCV) in tissue culture was established using the JFH1 isolate. To analyze determinants of HCV genome packaging and virion assembly, we developed a system that supports particle production based on trans-packaging of subgenomic viral RNAs. Using JFH1 helper viruses, we show that subgenomic JFH1 replicons lacking the entire core to NS2 coding region are efficiently encapsidated into infectious virus-like particles. Similarly, chimeric helper viruses with heterologous structural proteins trans-package subgenomic JFH1 replicons. Like authentic cell culture-produced HCV (HCVcc) particles, these trans-complemented HCV particles (HCV(TCP)) penetrate target cells in a CD81 receptor-dependent fashion. Since HCV(TCP) production was limited by competition between the helper and subgenomic RNA and to avoid contamination of HCV(TCP) stocks with helper viruses, we created HCV packaging cells. These cells encapsidate various HCV replicons with high efficiency, reaching infectivity titers up to 10(6) tissue culture infectious doses 50 per milliliter. The produced particles display a buoyant density comparable to HCVcc particles and can be propagated in the packaging cell line but support only a single-round infection in naïve cells. Together, this work demonstrates that subgenomic HCV replicons are assembly competent, thus excluding cis-acting RNA elements in the core-to-NS2 genomic region essential for RNA packaging. The experimental system described here should be helpful to decipher the mechanisms of HCV assembly and to identify RNA elements and viral proteins involved in particle formation. Similar to other vector systems of plus-strand RNA viruses, HCV(TCP) may prove valuable for gene delivery or vaccination approaches.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18480457      PMCID: PMC2446957          DOI: 10.1128/JVI.00118-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  67 in total

Review 1.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

2.  Hepatitis C virus core protein acts as a trans-modulating factor on internal translation initiation of the viral RNA.

Authors:  Sébastien Boni; Jean-Pierre Lavergne; Steeve Boulant; Annie Cahour
Journal:  J Biol Chem       Date:  2005-03-09       Impact factor: 5.157

Review 3.  Cell entry of hepatitis C virus.

Authors:  Birke Bartosch; François-Loïc Cosset
Journal:  Virology       Date:  2006-02-07       Impact factor: 3.616

4.  Viral and cellular determinants of hepatitis C virus RNA replication in cell culture.

Authors:  Volker Lohmann; Sandra Hoffmann; Ulrike Herian; Francois Penin; Ralf Bartenschlager
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

5.  An in vitro model of hepatitis C virion production.

Authors:  Theo Heller; Satoru Saito; Jonathan Auerbach; Tarice Williams; Tzivia Rachel Moreen; Allison Jazwinski; Brian Cruz; Neha Jeurkar; Ronda Sapp; Guangxiang Luo; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

6.  The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine.

Authors:  Stephen D C Griffin; Lucy P Beales; Dean S Clarke; Oliver Worsfold; Stephen D Evans; Joachim Jaeger; Mark P G Harris; David J Rowlands
Journal:  FEBS Lett       Date:  2003-01-30       Impact factor: 4.124

7.  Efficient rescue of hepatitis C virus RNA replication by trans-complementation with nonstructural protein 5A.

Authors:  Nicole Appel; Ulrike Herian; Ralf Bartenschlager
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

8.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

10.  Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons.

Authors:  Rainer Gosert; Denise Egger; Volker Lohmann; Ralf Bartenschlager; Hubert E Blum; Kurt Bienz; Darius Moradpour
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  79 in total

Review 1.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

2.  Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.

Authors:  Andreas Walker; Kathrin Skibbe; Eike Steinmann; Stephanie Pfaender; Thomas Kuntzen; Dominik A Megger; Svenja Groten; Barbara Sitek; Georg M Lauer; Arthur Y Kim; Thomas Pietschmann; Todd M Allen; Joerg Timm
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

3.  The acidic domain of hepatitis C virus NS4A contributes to RNA replication and virus particle assembly.

Authors:  Tung Phan; Andrew Kohlway; Peniel Dimberu; Anna Marie Pyle; Brett D Lindenbach
Journal:  J Virol       Date:  2010-11-03       Impact factor: 5.103

4.  Apolipoprotein E codetermines tissue tropism of hepatitis C virus and is crucial for viral cell-to-cell transmission by contributing to a postenvelopment step of assembly.

Authors:  Kathrin Hueging; Mandy Doepke; Gabrielle Vieyres; Dorothea Bankwitz; Anne Frentzen; Juliane Doerrbecker; Frauke Gumz; Sibylle Haid; Benno Wölk; Lars Kaderali; Thomas Pietschmann
Journal:  J Virol       Date:  2013-10-30       Impact factor: 5.103

5.  Alterations in the iron homeostasis network: A driving force for macrophage-mediated hepatitis C virus persistency.

Authors:  Pelagia Foka; Alexios Dimitriadis; Eirini Karamichali; Eleni Kyratzopoulou; Dionyssios Giannimaras; John Koskinas; Agoritsa Varaklioti; Avgi Mamalaki; Urania Georgopoulou
Journal:  Virulence       Date:  2016-04-08       Impact factor: 5.882

6.  Mouse-specific residues of claudin-1 limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line.

Authors:  Sibylle Haid; Marc P Windisch; Ralf Bartenschlager; Thomas Pietschmann
Journal:  J Virol       Date:  2009-11-04       Impact factor: 5.103

7.  Determining the involvement and therapeutic implications of host cellular factors in hepatitis C virus cell-to-cell spread.

Authors:  Naina Barretto; Bruno Sainz; Snawar Hussain; Susan L Uprichard
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

8.  Sigma-1 receptor regulates early steps of viral RNA replication at the onset of hepatitis C virus infection.

Authors:  Martina Friesland; Lidia Mingorance; Josan Chung; Francis V Chisari; Pablo Gastaminza
Journal:  J Virol       Date:  2013-03-27       Impact factor: 5.103

9.  Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.

Authors:  Julia Bitzegeio; Dorothea Bankwitz; Kathrin Hueging; Sibylle Haid; Christiane Brohm; Mirjam B Zeisel; Eva Herrmann; Marcus Iken; Michael Ott; Thomas F Baumert; Thomas Pietschmann
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

10.  The linker region of NS3 plays a critical role in the replication and infectivity of hepatitis C virus.

Authors:  Andrew Kohlway; Nathan Pirakitikulr; Steve C Ding; Feng Yang; Dahai Luo; Brett D Lindenbach; Anna M Pyle
Journal:  J Virol       Date:  2014-06-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.